ALLMedicine™ Ovarian Insufficiency Center
Research & Reviews 661 results
https://doi.org/10.1016/j.beem.2021.101577
Best Practice & Research. Clinical Endocrinology & Metabo... Rozenberg S, Di Pietrantonio V et. al.
Sep 19th, 2021 - This narrative review analyses the customization of Menopause Hormone Therapy in the context of breast cancer risk in women with premature ovarian insufficiency (POI) and with menopause at a normal age. Women with Idiopathic POI, FMR-1 premutation...
https://doi.org/10.1007/s43032-021-00728-7 10.1016/j.fertnstert.2008.10.006 10.1056/NEJM200006223422516 10.1093/humrep/den244 10.1634/theoncologist.12-12-1437 10.1056/NEJMc055237 10.1056/NEJMoa043157 10.1016/S0140-6736(04)17222-X 10.1016/j.jmig.2017.02.021 10.1159/000499054 10.3389/fendo.2018.00347 10.1007/s10815-018-1144-2 10.1056/NEJMra1614676 10.1093/humupd/dml032 10.1093/humupd/7.6.526 10.1016/S1472-6483(16)30187-0 10.1016/S1472-6483(16)30188-2 10.1080/08977194.2019.1680661 10.1159/000506303 10.1016/j.cryobiol.2015.11.001 10.1016/j.gep.2015.12.001 10.1016/j.ejogrb.2015.09.028 10.1007/s10439-017-1836-2 10.1007/s00441-013-1621-y 10.1530/REP-12-0233 10.1530/jrf.0.1060001 10.1002/jcp.27681 10.1002/biof.5520310202 10.1016/j.theriogenology.2011.07.007 10.1017/S0967199418000333 10.1007/s10815-011-9579-8 10.1016/S0015-0282(02)03110-2 10.1016/j.fertnstert.2006.10.012 10.1530/REP-13-0379 10.1016/j.rbmo.2014.09.013 10.1080/08977194.2016.1194835 10.1007/s12522-011-0100-y 10.1089/bio.2015.0021 10.1016/j.ultrasmedbio.2014.02.006 10.4274/jtgga.2017.0026 10.1016/S1472-6483(10)60424-5 10.1530/jrf.0.1010619 10.1038/301527a0 10.1095/biolreprod60.6.1462 10.1093/humrep/13.5.1133 10.1016/S0015-0282(99)00548-8 10.1016/S0015-0282(00)00548-3 10.1158/0008-5472.CAN-07-2042 10.1002/term.2870 10.1007/s10439-017-1817-5 10.1093/humrep/dev101 10.1530/REP-17-0483 10.1007/s10815-017-1051-y 10.1007/s10439-016-1780-6 10.1002/term.2214 10.1007/s10815-012-9757-3 10.1093/humrep/det338 10.2217/fon-2016-0202 10.1089/bio.2017.0087 10.1016/j.msec.2019.04.092
Reproductive Sciences (Thousand Oaks, Calif.); Khaleghi S, Fathi R et. al.
Sep 18th, 2021 - Ovarian tissue cryopreservation (OTC) holds promise for preservation of fertility among women who have lost their fertility due to diseases such as cancer. OTC has significantly assisted such cases by helping them maintain normal hormonal levels a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419036
Theranostics Zhang S, Zhu D et. al.
Sep 16th, 2021 - Rationale: Primary ovarian insufficiency (POI) normally occurs before age 40 and is associated with infertility. Hormone replacement therapy is often prescribed to treat vasomotor symptom, but it cannot restore ovarian function or fertility. Stem ...
https://doi.org/10.1093/molehr/gaab058
Molecular Human Reproduction; Cao D, Shi F et. al.
Sep 14th, 2021 - Non-obstructive azoospermia (NOA) and diminished ovarian reserve (DOR) are two disorders that can lead to infertility in male and female. Genetic factors have been identified to contribute to NOA and DOR. However, the same genetic factor that can ...
https://doi.org/10.1080/13697137.2021.1919460
Climacteric : the Journal of the International Menopause ... Panay N
Sep 10th, 2021 - Progress in understanding and management of premature ovarian insufficiency.|2021|Panay N,|
Guidelines 4 results
https://allmedx.com/USPSTFPDF/hormone-therapy-clinical-summary.pdf
Dec 5th, 2017 - Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women Population Postmenopausal women Postmenopausal women who have had a hysterectomy Recommendation Do not use combined estroge...
https://doi.org/10.1097/AOG.0000000000002044
Obstetrics and Gynecology;
Apr 21st, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...
https://doi.org/10.1093/humrep/dew027
Human Reproduction (Oxford, England); , Webber L et. al.
Mar 25th, 2016 - What is the optimal management of women with premature ovarian insufficiency (POI) based on the best available evidence in the literature? The guideline development group (GDG) formulated 99 recommendations answering 31 key questions on the diagno...
https://doi.org/10.1038/gim.2013.61
Genetics in Medicine : Official Journal of the American C... Monaghan KG, Lyon E et. al.
Jun 15th, 2013 - Molecular genetic testing of the FMR1 gene is commonly performed in clinical laboratories. Mutations in the FMR1 gene are associated with fragile X syndrome, fragile X tremor ataxia syndrome, and premature ovarian insufficiency. This document prov...
News 26 results
https://www.medscape.com/viewarticle/951400
May 18th, 2021 - Primary ovarian insufficiency is not your mother's early menopause, Laurie McKenzie, MD, told attendees at the 2021 annual meeting of the American College of Obstetricians and Gynecologists. Known previously as primary ovarian failure, the syndrom...
https://www.medscape.com/viewarticle/947390
Mar 15th, 2021 - NEW YORK (Reuters Health) - Primary ovarian insufficiency (POI) was tied to an increased risk of osteoporosis in a large Canadian cohort study. "There is accumulating evidence demonstrating that an earlier menopause, which represents an early loss...
https://www.medscape.com/viewarticle/921541
Nov 21st, 2019 - NEW YORK (Reuters Health) - After three years of adverse-event surveillance and more than 28 million doses, the nine-valent human papillomavirus (9vHPV) vaccine shows no new or unexpected safety concerns, according to results from two studies. "Th...
https://www.medscape.com/viewarticle/919637
Oct 18th, 2019 - In the reviewed guideline: ‘Menopause: diagnosis and management’ the National Institute for Health and Care Excellence (NICE) aims to improve the consistency of support and information provided to women in menopause. It includes guidance for the d...
https://www.mdedge.com/obgyn/article/172987/vaccines/no-increase-primary-ovarian-insufficiency-hpv-vaccine
Bianca Nogrady
Aug 21st, 2018 - The human papillomavirus vaccine does not appear to be associated with an increased risk of ovarian insufficiency, according to researchers. Choreograph/Thinkstock Allison L.
